Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings
Introduction Harms due to methamphetamine use disorder (MAUD) are rising globally. Untreated withdrawal symptoms perpetuate the cycle of dependence and are a barrier to treatment. There is no pharmacotherapy approved for methamphetamine withdrawal. Lisdexamfetamine (LDX) dimesylate has potential as...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2025-11-01
|
| Serier: | BMJ Open |
| Online adgang: | https://bmjopen.bmj.com/content/15/11/e107242.full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
